| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/22/2011 | US7910556 PAR-2 agonist |
| 03/22/2011 | US7910555 C-Met receptor regulation by angiotensin IV (AT4 ) receptor ligands |
| 03/22/2011 | US7910554 Biodrugs comprising polypeptides and carriers comprising bioadhesives such as fibrin, for treatment of vision defects; chimeric C3-like Rho antagonists and their use for promoting repair and neuron survival in injured mammalian central and peripheral nervous system and for treating cancer |
| 03/22/2011 | US7910552 Bone morphogenetic proteins containing a heparin binding site and osteogenic devices and pharmaceutical products containing thereof |
| 03/22/2011 | US7910551 Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 03/22/2011 | US7910550 Human kunitz-type inhibitor with enhanced antifibrinolytic activity |
| 03/22/2011 | US7910549 MN gene and protein |
| 03/22/2011 | US7910548 Methods for treating obesity |
| 03/22/2011 | US7910547 Tissue regeneration method |
| 03/22/2011 | US7910545 Combination enzyme replacement and small molecule therapy for treatment of lysosomal storage diseases |
| 03/22/2011 | US7910544 Conformationally constrained parthyroid hormone (PTH) analogs |
| 03/22/2011 | US7910543 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors |
| 03/22/2011 | US7910542 Methods for promoting wound healing and muscle regeneration with the cell signaling protein Nell1 |
| 03/22/2011 | US7910541 Enzyme treatment of foodstuffs for celiac sprue |
| 03/22/2011 | US7910540 Soluble ZcytoR14, anti-ZcytoR14 antibodies and binding partners and methods of using in inflammation |
| 03/22/2011 | US7910370 Treating and preventing cell proliferative, neurodegenerative and viral infections via enhancing oncogenic protein expression |
| 03/22/2011 | US7910364 Rapidly cleavable sumo fusion protein expression system for difficult to express proteins |
| 03/22/2011 | US7910135 Hydrogel wound dressing and biomaterials formed in situ and their uses |
| 03/22/2011 | US7910132 Pharmaceutical composition for the treatment of acute disorders |
| 03/22/2011 | US7910126 Flexible, compressed intravaginal rings, methods of making and using the same, and apparatus for making the same |
| 03/22/2011 | US7910123 Methods of treating a trauma or disorder of the knee joint by local administration and sustained-delivery of a biological agent |
| 03/22/2011 | US7910116 Use of a botulinum toxin to improve gastric emptying and/or to treat GERD |
| 03/22/2011 | US7910115 Polypeptide absorbable into digestive organs |
| 03/22/2011 | US7910109 Major histocompatibility complex epitope for use in treatment and prevention of cell proliferative disorders; immunotherapy |
| 03/22/2011 | US7910105 Methods for treating and preventing fibrosis |
| 03/22/2011 | US7910103 Immunotherapy of B-cell malignancies using anti-CD22 antibodies |
| 03/22/2011 | US7910102 Methods of using conjugated toxin peptide therapeutic agents |
| 03/22/2011 | US7910101 Melanocortin receptor binding mimetibodies, compositions, methods and uses |
| 03/22/2011 | US7910095 Using immunoglobulin specific to shiga-like toxin as therapeutic tool in treatment and prevention of enterohemorrhagic escherichia infection |
| 03/22/2011 | US7910094 Composition exhibiting a von willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV |
| 03/22/2011 | US7910089 Sialogogue, oral composition and food product containing the same |
| 03/22/2011 | CA2480273C Ph-sensitive polymer |
| 03/22/2011 | CA2471769C Oral insulin therapy |
| 03/22/2011 | CA2461380C Hepatitis c virus vaccine |
| 03/22/2011 | CA2450587C Natural ligand of g protein coupled receptor chemr23 and uses thereof |
| 03/22/2011 | CA2433675C Pharmaceutically active piperidine derivatives |
| 03/22/2011 | CA2427072C N-alkylglycine trimers capable of protecting neurons against excitotoxic aggressions and compositions containing said trimers |
| 03/22/2011 | CA2417331C Transplant media comprising bnp-1 |
| 03/22/2011 | CA2412050C A recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses |
| 03/22/2011 | CA2406201C Improvements in or relating to formulations for use in inhaler devices |
| 03/22/2011 | CA2396519C A process for isolation of osteopontin from milk |
| 03/22/2011 | CA2390166C Hedgehog fusion proteins and uses |
| 03/22/2011 | CA2362937C Taxane derivatives for targeted therapy of cancer |
| 03/22/2011 | CA2308127C Agonist and antagonist peptides of carcinoembryonic antigen (cea) |
| 03/22/2011 | CA2304808C Liquid interferon-.beta. formulations |
| 03/22/2011 | CA2264483C Method for recombinant adeno-associated virus-directed gene therapy |
| 03/22/2011 | CA2240409C Mammalian cx3c chemokine genes |
| 03/22/2011 | CA2236159C Vp antigens of the jc virus |
| 03/22/2011 | CA2173750C Single-chain forms of the glycoprotein hormone quartet |
| 03/22/2011 | CA2136958C Method for inhibition of viral morphogenesis |
| 03/17/2011 | WO2011032161A2 Vaccines directed to langerhans cells |
| 03/17/2011 | WO2011031901A1 Actriib antagonists and dosing and uses thereof |
| 03/17/2011 | WO2011031884A2 Methods and materials for modulating deubiquitinases and ubiquitinated polypeptides |
| 03/17/2011 | WO2011031856A1 Bmp -7 for use in treating pain induced by injuries and diseases of an articular joint |
| 03/17/2011 | WO2011031713A2 Method for the treatment of pulmonary disease and method of producing proteins of use therein |
| 03/17/2011 | WO2011031676A2 Depleting immunosuppressive monocytes within a mammal |
| 03/17/2011 | WO2011031662A1 Ester insulin |
| 03/17/2011 | WO2011031600A1 Use of il-33 antagonists to treat fibrotic disease |
| 03/17/2011 | WO2011031567A1 Novel nucleoside phosphonates and analogs |
| 03/17/2011 | WO2011031561A2 Nucleic acid molecules and uses thereof |
| 03/17/2011 | WO2011031525A1 Osteolysis treatment |
| 03/17/2011 | WO2011031477A2 Nucleolin-binding peptides, nucleolin-binding lytic peptides, fusion constructs and methods of making and using same |
| 03/17/2011 | WO2011031476A2 Compositions and methods for treatment or prevention of post-operative organ or tissue inflammation |
| 03/17/2011 | WO2011031460A2 Novel anti-inflammatory peptides that bind oxidized phospholipids |
| 03/17/2011 | WO2011031187A1 Antimicrobial agents based on hemin derivatives |
| 03/17/2011 | WO2011031180A1 Method for stimulating super ovulation in donor cows |
| 03/17/2011 | WO2011030895A1 Mouse pheromone |
| 03/17/2011 | WO2011030892A1 Novel substrate peptide for rho-kinase |
| 03/17/2011 | WO2011030847A1 Inducer composition for hematopoietic stem cells |
| 03/17/2011 | WO2011030774A1 Pth-containing therapeutic/prophylactic agent for osteoporosis, characterized in that pth is administered once a week at unit dose of 100 to 200 units |
| 03/17/2011 | WO2011030568A1 Therapeutic agent for small cell lung cancer |
| 03/17/2011 | WO2011030552A1 Root canal filler for non-extracted tooth and non-extraction method for regenerating dental tissue |
| 03/17/2011 | WO2011030332A2 Methods for hematopoietic precursor mobilization |
| 03/17/2011 | WO2011030329A1 Method of treating tumors |
| 03/17/2011 | WO2011030296A1 Molecules capable of inducing cell death by targeting the mitochondria and applications thereof |
| 03/17/2011 | WO2011029980A1 Therapeutic compositions for the treatment of hpv-induced diseases |
| 03/17/2011 | WO2011029931A1 Composition for treatment of cxcl8-mediated lung inflammation |
| 03/17/2011 | WO2011029870A1 Use of interleukin-1 beta mutein conjugates in the treatment of diabetes |
| 03/17/2011 | WO2011029861A1 Plgf-1 in homodimeric form |
| 03/17/2011 | WO2011029696A1 Directed evolution of arginine deiminase for increased activity at physiological ph |
| 03/17/2011 | WO2011029525A1 A therapeutic combination comprising a pulmonary surfactant and antioxidant enzymes |
| 03/17/2011 | WO2010136841A3 Meganuclease variants cleaving the genome of a non-genomically integrating virus and uses thereof |
| 03/17/2011 | WO2010131909A3 Pharmaceutical preparation to be administered into respiratory organs for treating or preventing inflammatory respiratory diseases, and method for treating or preventing such diseases |
| 03/17/2011 | WO2010129789A3 Modified tumor necrosis factor-beta |
| 03/17/2011 | WO2010122367A3 Meganuclease variants cleaving the genomic insertion of a virus and uses thereof |
| 03/17/2011 | WO2010118435A3 Par-1 activation by metalloproteinase-1 (mmp-1) |
| 03/17/2011 | WO2010114275A3 Composition for inhibiting erythema caused by ultraviolet radiation containing a dipeptide as active ingredient |
| 03/17/2011 | WO2010085588A8 Modulating angiogenesis |
| 03/17/2011 | WO2009146886A9 Antibacterial peptides |
| 03/17/2011 | US20110067126 Gab1 involvement in glucose homeostasis regulation by hepatocytes |
| 03/17/2011 | US20110066251 Anti-angiogenic compositions and methods of use |
| 03/17/2011 | US20110066230 Fluorinated GHRH Antagonists |
| 03/17/2011 | US20110066182 Tissue Sealant for Use in Non Compressible Hemorrhage |
| 03/17/2011 | US20110066112 Reduced volume formulation of glatiramer acetate and methods of administration |
| 03/17/2011 | US20110066101 Non-invasive ocular drug delivery |
| 03/17/2011 | US20110065799 Urokinase inhibitors, production and use thereof |
| 03/17/2011 | US20110065780 Insulin resistance improving agent |
| 03/17/2011 | US20110065778 RNA Interference Mediated Inhibition of Muscarinic Colinergic Receptor Gene Expression Using Short Interfering Nucleic Acid (siNA) |
| 03/17/2011 | US20110065777 DOUBLE-STRANDED RNA (dsRNA) AND METHOD OF USE FOR INHIBITING EXPRESSION OF A FUSION GENE |
| 03/17/2011 | US20110065773 Rna interference mediating small rna molecules |